Voloridge Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.9M Sell
27,531
-1,723,476
-98% -$119M 0.01% 958
2025
Q1
$122M Buy
1,751,007
+298,835
+21% +$20.8M 0.45% 39
2024
Q4
$125M Buy
1,452,172
+833,966
+135% +$71.7M 0.44% 36
2024
Q3
$73.6M Buy
+618,206
New +$73.6M 0.27% 90
2024
Q2
Sell
-52,788
Closed -$6.78M 1325
2024
Q1
$6.78M Buy
+52,788
New +$6.78M 0.02% 574
2023
Q4
Sell
-748,057
Closed -$68M 1374
2023
Q3
$68M Sell
748,057
-8,445
-1% -$768K 0.34% 73
2023
Q2
$61.2M Buy
756,502
+10,622
+1% +$859K 0.29% 82
2023
Q1
$59.3M Sell
745,880
-135,144
-15% -$10.8M 0.3% 80
2022
Q4
$59.6M Buy
881,024
+308,948
+54% +$20.9M 0.33% 60
2022
Q3
$28.5M Buy
572,076
+290,648
+103% +$14.5M 0.15% 187
2022
Q2
$15.7M Buy
+281,428
New +$15.7M 0.08% 324
2022
Q1
Sell
-176,500
Closed -$9.88M 1606
2021
Q4
$9.88M Buy
176,500
+156,818
+797% +$8.78M 0.05% 473
2021
Q3
$945K Buy
+19,682
New +$945K 0.01% 1300
2020
Q4
Sell
-195,974
Closed -$6.8M 1493
2020
Q3
$6.8M Buy
195,974
+65,928
+51% +$2.29M 0.06% 359
2020
Q2
$4.26M Sell
130,046
-122,630
-49% -$4.02M 0.05% 397
2020
Q1
$7.61M Sell
252,676
-196,036
-44% -$5.9M 0.22% 103
2019
Q4
$13M Buy
448,712
+275,606
+159% +$7.98M 0.25% 89
2019
Q3
$4.48M Buy
173,106
+107,630
+164% +$2.78M 0.08% 281
2019
Q2
$1.67M Buy
+65,476
New +$1.67M 0.05% 358
2018
Q4
Sell
-34,526
Closed -$814K 460
2018
Q3
$814K Sell
34,526
-323,916
-90% -$7.64M 0.02% 232
2018
Q2
$8.27M Buy
358,442
+216,010
+152% +$4.98M 0.22% 107
2018
Q1
$3.51M Sell
142,432
-113,704
-44% -$2.8M 0.08% 212
2017
Q4
$6.87M Buy
+256,136
New +$6.87M 0.15% 158
2017
Q2
Sell
-188,048
Closed -$3.22M 524
2017
Q1
$3.22M Buy
+188,048
New +$3.22M 0.08% 269
2015
Q3
Sell
-128,728
Closed -$3.53M 369
2015
Q2
$3.53M Buy
+128,728
New +$3.53M 0.18% 130